Clinical Trials Browser

Recruiting × Solid Tumors × pembrolizumab × Clear all

NCT05101070 2026-03-18

aCCeleR8-001

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors

NCT07158918 2025-09-08

ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors